Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04020718 · ClinicalTrials.gov registry record · Phase 4
Engagement With an Adaptive Mobile Health Smoking Cessation Intervention
A Phase 4 study of Tobacco Use Cessation, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT04020718 is a Phase 4 study of Tobacco Use Cessation that has completed, run by Massachusetts General Hospital. The registered enrollment target is 35 participants, below the 884-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04020718, a Phase 4 study of Tobacco Use Cessation, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot sequential multiple assignment trial (SMART) to understand the optimal timing to assess response to our smoking cessation text message intervention and to measure how adding medications alone compares to adding medications and telephone coaching for those who continue to smoke. This study aims to assess the feasibility of a SMART of a proactively offered text message intervention for smokers in primary care that compares early (4 weeks) versus late (8 weeks) assessment of treatment response and the addition of nicotine replacement therapy (NRT) alone or with telephone coaching for non-responders.
Conditions Studied
Interventions
- BEHAVIORAL Brief telephone advice plus tailored text messages
- DRUG Mailed nicotine replacement therapy
- BEHAVIORAL Proactive telephone coaching
Study Locations (1)
Massachusetts
- Massacusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2020-01-31 |
| Est. Completion | 2020-11-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04020718
The ClinicalTrials.gov registry entry for NCT04020718 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 884-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (96% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tobacco Use Cessation appearing as the primary indexed condition, and to 3 interventions - of which Brief telephone advice plus tailored text messages is the first listed.
NCT04020718 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04020718 about?
NCT04020718 is a clinical study titled "Engagement With an Adaptive Mobile Health Smoking Cessation Intervention". This is a pilot sequential multiple assignment trial (SMART) to understand the optimal timing to assess response to our smoking cessation text message intervention and to measure how adding medications alone compares to adding medications and telephone coaching for those who continue to smoke. This ...
What is the current status of trial NCT04020718?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2020-01-31. Estimated completion is 2020-11-30.
What conditions does trial NCT04020718 study?
This clinical trial studies the following conditions: Tobacco Use Cessation.
What interventions are being tested in trial NCT04020718?
The interventions under investigation include: Brief telephone advice plus tailored text messages (BEHAVIORAL), Mailed nicotine replacement therapy (DRUG), Proactive telephone coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT04020718?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04020718 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
Reward Sensitivity and Pharmacotherapy for Smoking Cessation
ACTIVE NOT RECRUITING · Phase 4
-
A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV
COMPLETED · Phase 4
-
Cannabis-Tobacco Co-Use Treatment Study
RECRUITING · Phase 3
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.